Viewing Study NCT02324556


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-03 @ 12:48 AM
Study NCT ID: NCT02324556
Status: TERMINATED
Last Update Posted: 2020-04-28
First Post: 2014-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A LAparoscopic and TransAnal Total Mesorectal Excision (TME) for Rectal Cancer Trial
Sponsor: Sahlgrenska University Hospital
Organization:

Study Overview

Official Title: A LAparoscopic and TransAnal Total Mesorectal Excision (TME for Rectal Cancer Trial
Status: TERMINATED
Status Verified Date: 2020-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Patients are currently being operated in the robot instead due to logistics
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LATA
Brief Summary: All patients planned for an anterior resection due to rectal cancer with a total mesorectal excision are included. This is a feasibility study, thus no randomization will be performed.

Primary endpoint is clinical and pathologic examination of the specimen. Secondary end-points include clinical variables such as conversion rate, re-admission and/or re-operation due to any complication and health economy analyses.
Detailed Description: The design is comparative and prospective, we will compare specimens from patients operated at our institution during the last year with standard open or laparoscopic approach with patients operated with the new technique. Patients in the control arm will be patients operated prior to the commencement of the new technique or patients not eligible or possible to include in the study.

It is possible to obtain a macroscopically and microscopically adequate specimen after a combined approach with laparoscopic and transanal TME compared to open or laparoscopic conventional TME.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: